Increased expression of cystatin C in cerebrospinal fluid has been highlighted in many neurodegenerative disorders, including Alzheimer’s disease, and it was suggested to be of diagnostic interest (Deng et al. 2001; Yamamoto-Watanabe et al. 2010). This evidence concerns the gene CST3 and early-onset autosomal dominant Alzheimer disease.